SMTI insider trading
NasdaqCM HealthcareSanara MedTech Inc.: insider trade history from SEC Form 4 filings.
About Sanara MedTech Inc.
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Company website: sanaramedtech.com
SMTI insider activity at a glance
FilingIQ tracks 218 insider transactions for SMTI in filings since Oct 17, 2019. The most recent transaction is dated Sep 15, 2026.
Across the full history, 3 open-market purchases
and 18 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SMTI insider trades is 65.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SMTI Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading SMTI
Frequently asked
- How many insider trades does FilingIQ track for SMTI?
- FilingIQ tracks 218 Form 4 insider transactions for SMTI (Sanara MedTech Inc.), covering filings from Oct 17, 2019 onwards. 1 of those are dated within the last 90 days.
- Are SMTI insiders net buyers or net sellers?
- Across the full Form 4 history for SMTI, 3 transactions (1%) were open-market purchases and 18 (8%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SMTI insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is SMTI in?
- Sanara MedTech Inc. (SMTI) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $171.56M.
Methodology & sources
Every SMTI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.